MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tremors: Clinical features"

  • 2024 International Congress

    Jaw Clonus Masquerading as Jaw Tremor in a case of Amyotrophic Lateral Sclerosis (ALS)

    A. Boddu (Little Rock, USA)

    Objective: To highlight the importance of distinguishing jaw clonus from jaw tremor which can be a useful sign in clinical diagnosis by reporting a case…
  • 2024 International Congress

    Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

    MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

    Objective: The aim of our study was to observe the clinical characteristics of different movement disorders (MD) in patients with multiple sclerosis (MS). Background: Demyelinating…
  • 2024 International Congress

    Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor

    B. Lavenstein, P. Mcgurrrin, F. Vial, E. Akano, S. Attaripour, P. Panyakaew, A. Choi, L. Pesantez-Pacheco, H. Lin, M. Hallett (Bethesda, USA)

    Objective: We explored the utility of noninvasive electrophysiological tremor studies in patients referred  for evaluation by pediatric movement specialists  following their clinical assessment . The…
  • 2024 International Congress

    Longitudinal Analysis of fragile X-associated tremor/ataxia syndrome Progression: A One-Year Follow-Up of 24 Patients

    M. Tosin, D. Hall, L. Quinchia (Chicago, USA)

    Objective: Determine the rate of progression of motor signs in fragile X-associated tremor/ataxia syndrome (FXTAS) over a one-year follow-up. Background: Limited information exists regarding the…
  • 2024 International Congress

    Levels of change in interleukin-6 levels according to clinical forms of Parkinson’s disease in patients with and without Covid-19

    B. Muminov, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in clinical forms Parkinson's disease (PD) patients with and without Сovid-19. Background: Changes in the treatment after infection with…
  • 2024 International Congress

    Evaluation of Functional Impairment and Treatment Satisfaction in Patients With Essential Tremor: a Cross-Sectional Study of Physicians Using Real-World Data

    T. Saifee, L. Barbato, J. Lin, A. Sillah, M. Baladi, S. Thomas, A. Gillespie, L. Harrison, S. Shah (London, United Kingdom)

    Objective: To describe the impact of tremor on activities of daily living (ADL) and treatment satisfaction in patients with essential tremor (ET). Background: ET, a…
  • 2024 International Congress

    Medication Effects on Bradykinesia and Tremor in Parkinson’s Disease, Measured by Wearable Sensors

    R. Weijer, A. Szanto, V. Exadaktylos, J. van Hilten, D. Hepp (Leiden, Netherlands)

    Objective: To determine the responsiveness to the effects of medication of home based unsupervised wearable sensor assessed tests for the evaluation of bradykinesia and tremor…
  • 2024 International Congress

    Tremulous Machado-Joseph Disease

    V. Procaci, L. de Farias, S. da Costa, O. Barsottini, J. Pedroso (Sao Paulo, Brazil)

    Objective: To describe a case of spinocerebellar ataxia type 3 (SCA3) presenting with tremor. Background: Tremor is not a frequent manifestation in SCA3, especially as…
  • 2024 International Congress

    Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor

    L. Shih, M. Stevenson, S. Bellows, A. Fasano, S. Kuo, K. Lyons, H. Moore, H. Shill, A. Shukla, C. Singer, R. Elble (Boston, USA)

    Objective: Develop and validate a TETRAS PRO subscale Background: The Essential Tremor Rating Assessment Scale (TETRAS) is a popular scale for essential tremor (ET), but…
  • 2024 International Congress

    Disease Burden and Treatment in Patients With Essential Tremor in the United States: Real-World Evidence From a Cross-Sectional Survey of Physicians and Patients

    J. Williams, A. Gillespie, L. Harrison, S. Thomas, A. Sillah, L. Barbato, J. Lin, S. Shah (Bakersfield, USA)

    Objective: To characterize disease burden and medication treatment insights in patients with essential tremor (ET) using Adelphi Essential Tremor Disease Specific Programme (DSP)TM data. Background:…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 23
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley